Pulsed electromagnetic field therapy alters the genomic profile of bladder cancer cell line HT-1197. Pulsed electromagnetic field therapy alters the genomic profile of bladder cancer cell line HT-1197

Bladder cancer cell lines were subjected to either pulsed electromagnetic field therapy (PEMF) or control (no PEMF) 1 hour/day for a total of 5 days to assess changes in genomic analysis. Overall design: Results showed that post electromagnetic field therapy resulted in significant changes to genome expression of bladder cancer cells subjected to PEMF.